While disappointing clinical trial results are not only common, they're what most investors should ultimately expect (only about 10 to 15% of new drugs make it to market). Even so, last week saw three highly-anticipated biotech events all go against long investors.
Very nice! Just knowing the statistics tells a lot how to be a successful trader – just go short with ALL biotech stocks!
No comments:
Post a Comment